腫瘤切除術市場規模、佔有率、成長分析，按消融類型、按手術類型、按應用、按最終用戶、按地區 - 行業預測，2025-2032

2023年全球腫瘤切除術市場規模估值為13.2億美元，從2024年的15億美元擴大到2032年的41.6億美元，在預測期內（2025-2032年）預計複合年成長率為13.6%。

由於對更安全的替代療法的需求不斷成長以及癌症發病率的不斷上升，治療選擇市場預計將大幅成長，特別是在高所得國家，預計該地區 80% 以上的人口將大幅成長。對微創和非侵入性治療的日益偏好預計將進一步支持市場擴張。先進的腫瘤消融技術因其更快的恢復時間和更高的舒適度而受到外科醫生和患者的青睞。與傳統治療相比，這些門診病人技術降低了整體醫療成本。此外，切除手術正成為小腫瘤的首選選擇，凸顯了年度癌症篩檢率對手術數量的間接影響。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 價格分析
• 技術分析
• 監管分析
• 專利分析
• 案例研究

腫瘤切除術市場規模：依消融類型分類

• 市場概況
• 射頻消融術(RFA)
• 微波消融 (MWA)
• 雷射消熔
• 冷凍療法
• 不可逆電穿孔 (IRE)
• 高強度聚焦超音波（HIFU）
• 其他

腫瘤切除術市場規模：依手術類型

• 市場概況
• 微創消融
• 手術消融

腫瘤切除術市場規模：依應用分類

• 市場概況
• 肝癌
• 肺癌
• 腎癌
• 乳癌
• 攝護腺癌
• 骨癌
• 其他

腫瘤切除術市場規模：依最終用戶分類

• 市場概況
• 醫院
• 癌症研究組織
• 專科診所
• 日間手術中心 (ASC)

腫瘤切除術市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Angiodynamics（Covidien）（US）
• Boston Scientific Corporation（US）
• Medtronic Plc（US）
• Ethicon, Inc.（US）
• Galil Medical Inc.（US）
• Misonix Inc.（US）
• HealthTronics（US）
• Mermaid Medical（Denmark）
• Theraclion（France）
• Chongqing Haifu Medical Technology Co., Ltd.（China）
• HS Hospital Service SPA（Italy）
• Hologic, Inc.（US）
• Varian Medical Systems（US）
• Cook Medical（US）
• LeVeen Medical（US）
• Integra LifeSciences（US）
• MedWaves, Inc.（US）
• Sanarus Technologies, Inc.（US）
• Bovie Medical Corporation（US）
• ThermoLife（US）

結論和建議

Global Oncology Ablation Market size was valued at USD 1.32 billion in 2023 and is poised to grow from USD 1.5 billion in 2024 to USD 4.16 billion by 2032, growing at a CAGR of 13.6% during the forecast period (2025-2032).

The market for therapeutic options is poised for significant growth driven by the escalating need for safer treatment alternatives and the increasing incidence of cancer, especially in low-income countries where cases are projected to surge by over 80%, compared to 41% in high-income regions. The growing inclination toward minimally invasive and non-invasive procedures is expected to further boost market expansion. Advanced tumor ablation techniques are gaining traction as both surgeons and patients favor these methods for their quick recovery times and enhanced comfort. Characterized as outpatient procedures, these techniques reduce overall healthcare costs compared to conventional treatments. Additionally, ablative surgery is becoming the preferred option for smaller tumors, highlighting the indirect influence of annual cancer screening rates on procedural volume.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oncology Ablation Market Segmental Analysis

Global Oncology Ablation Market is segmented by Type of Ablation, Procedure Type, Application, End User and region. Based on Type of Ablation, the market is segmented into Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Laser Ablation, Cryoablation, Irreversible Electroporation (IRE), High-Intensity Focused Ultrasound (HIFU) and Others. Based on Procedure Type, the market is segmented into Minimally Invasive Ablation and Surgical Ablation. Based on Application, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Cancer and Others. Based on End User, the market is segmented into Hospitals, Cancer Research Institutes, Specialty Clinics and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oncology Ablation Market

The global oncology ablation market is experiencing a significant boost in demand for advanced tumor ablation techniques, which is expected to persist throughout the forecast period. This surge is largely attributed to the growing preference among both surgeons and patients for minimally invasive procedures. The advantages associated with these techniques, such as reduced recovery times, enhanced patient comfort, and faster return to normal activities, are increasingly influencing decisions in favor of oncological interventions. As awareness and acceptance of these benefits continue to rise, the oncology ablation market is poised for substantial growth, reflecting a broader trend towards innovative and less invasive treatment options.

Restraints in the Global Oncology Ablation Market

The Global Oncology Ablation market faces several constraints primarily due to the complexities associated with ablation treatments. While tumor ablation therapy is gaining traction as a viable option for various solid organ cancers, the intricacies involved in the procedures can be daunting. Common complications such as blood loss and injuries to the target organ pose significant risks, categorized according to their associated threats. These adverse effects not only jeopardize patient safety but also increase the hesitance surrounding the adoption of these procedures, ultimately hindering market growth and limiting the wider acceptance of oncology ablation therapies in clinical settings.

Market Trends of the Global Oncology Ablation Market

The Global Oncology Ablation market is witnessing a significant shift as cooled radiofrequency probes gain traction among healthcare providers aiming for improved treatment methods. Market players are prioritizing technological advancements that enhance the precision, portability, and affordability of ablation techniques. Innovations such as High-Intensity Focused Ultrasound (HIFU), cryoablation, and image-guided equipment are at the forefront of this evolution. Notably, the advent of cooled radiofrequency denervation techniques is emerging as a critical contributor to market growth, facilitating complete denervation of the sacroiliac joint to effectively manage pain. This trend highlights a progressive move towards more efficient and impactful cancer treatment solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Oncology Ablation Market Size by Type of Ablation & CAGR (2025-2032)

• Market Overview
• Radiofrequency Ablation (RFA)
• Microwave Ablation (MWA)
• Laser Ablation
• Cryoablation
• Irreversible Electroporation (IRE)
• High-Intensity Focused Ultrasound (HIFU)
• Others

Global Oncology Ablation Market Size by Procedure Type & CAGR (2025-2032)

• Market Overview
• Minimally Invasive Ablation
• Surgical Ablation

Global Oncology Ablation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Breast Cancer
• Prostate Cancer
• Bone Cancer
• Others

Global Oncology Ablation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Cancer Research Institutes
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)

Global Oncology Ablation Market Size & CAGR (2025-2032)

• North America (Type of Ablation, Procedure Type, Application, End User)
  • US
  • Canada
• Europe (Type of Ablation, Procedure Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Ablation, Procedure Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Ablation, Procedure Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Ablation, Procedure Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Angiodynamics (Covidien) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galil Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Misonix Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthTronics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mermaid Medical (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theraclion (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing Haifu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HS Hospital Service S.P.A (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeVeen Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedWaves, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanarus Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bovie Medical Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ThermoLife (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations